Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000673922 | SCV000799178 | likely pathogenic | Hurler syndrome | 2018-04-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001247821 | SCV001421266 | pathogenic | Mucopolysaccharidosis type 1 | 2023-06-30 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 557744). Disruption of this splice site has been observed in individuals with MPS I (PMID: 22976768; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change affects an acceptor splice site in intron 12 of the IDUA gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in IDUA are known to be pathogenic (PMID: 11735025, 21480867). |
Revvity Omics, |
RCV001784289 | SCV002023105 | pathogenic | not provided | 2020-04-22 | criteria provided, single submitter | clinical testing |